Skip to main content

Table 4 Effect of detection mode on death from breast cancer and all causes other than breast cancer after incident breast cancer diagnosis based on n = 68,230 women aged 50–69 years

From: Isolating the effect of confounding from the observed survival benefit of screening participants — a methodological approach illustrated by data from the German mammography screening programme

 

Death from breast cancer

Death from all causes other than breast cancer

HR (95% CI)

HR (95% CI)

Models without adjustment

 MSP non-participants

1

1

 MSP participants with interval-detected BC

0.63 (0.59–0.68)

0.65 (0.58–0.72)

 MSP participants with screen-detected BC

0.22 (0.20–0.23)

0.65 (0.62–0.70)

Models adjusted for age at diagnosis and year of diagnosis

 MSP non-participants

1

1

 MSP participants with interval-detected BC

0.62 (0.58–0.66)

0.63 (0.56–0.70)

 MSP participants with screen-detected BC

0.21 (0.20–0.22)

0.62 (0.58–0.66)

Models adjusted for age at diagnosis, year of diagnosis and tumour stage

 MSP non-participants

1

 

 MSP participants with interval-detected BC

0.70 (0.65–0.76)

 

 MSP participants with screen-detected BC

0.42 (0.39–0.45)

 
  1. MSP Mammography screening programme, BC Breast cancer, HR Hazard ratio, CI Confidence interval